Fetal growth restriction (FGR)

Fetal growth restriction (FGR)

Fetal growth restriction (FGR) is a common pregnancy complication where an unborn baby fails to thrive.

FGR can put babies at risk of cardiovascular disease, lung and brain injury and life-long problems like cerebral palsy, autism, learning and other behavioural dysfunctions.

What is FGR?

What causes FGR?

What are FGR risk factors?

Our fetal growth restriction (FGR) research

The period from conception through to neonatal life is critical in determining the health of a baby and subsequent life-long health.

Our FGR researchers aim to improve health outcomes for women and babies by investigating how maternal and fetal treatments including nutrition and the intrauterine environment affect growth, development and long-term health.

Hudson Institute scientists work in close collaboration with Monash Health clinicians who treat women and babies affected by FGR.

Improving the transition at birth in newborns with growth restriction.

Associate Professor Graeme Polglase, Research Group Head, Perinatal Transition Research Group at Hudson Institute of Medical Research

Clinical practice. Professor Graeme Polglase’s project aims to determine the cardiovascular adaptations that a growth restricted fetus takes to survive chronic hypoxia, and how this alters the cardiovascular transition at birth, making the newborn prone to cardiovascular disease and brain injury. The team also aim to identify strategies to improve cardiovascular function in growth restricted newborns.

Team | Professor Graeme Polglase, Dr Beth Allison, Professor Stuart Hooper AM, Dr Emily Camm

Improving functional deficits associated with fetal growth restriction

Investigating the effect of birth asphyxia in growth restricted newborns.

Early diagnosis of brain injury associated with FGR

Assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset FGR

The effects of FGR on the developing preterm lung and cardiovascular system

Protect Me Trial

ProtectMe Trial – fetal growth restriction (FGR)

Are you pregnant with a baby with FGR?

This trial looks at the use of melatonin to protect the developing brain of babies with fetal growth restriction (FGR) during pregnancy.

More information >

Fetal growth restriction (FGR) collaborators

To solve health challenges our leading scientists, collaborate with experts in their field nationally and internationally. This includes working with clinicians and scientists on priority health challenges, identification at a molecular level through to clinical trial and application of results in clinics.

Support for Fetal growth restriction (FGR)

Hudson Institute scientists cannot provide medical advice.
Find out more about Fetal growth restriction (FGR).

Share this page